Danish chemical industry news

• 

  28 April 2026

  REMONDIS: Closing the Textile Loop

  Joint initiatives improve textile collection, sorting and recycling; mechanical and chemical recycling needed for mixed fibres. EPR funding and eco-modulation to fund infrastructure and boost reuse.
• 

  24 April 2026

  EMA recommends Redemplo for adults with familial chylomicronaemia syndrome (FCS)

  siRNA blocking APOC3 cut triglycerides 80% vs 17% in trial; lowered acute pancreatitis rates; given subcutaneously every 3 months; common AEs: hyperglycaemia, headache, nausea.
• 

  20 April 2026

  Siemens and Vulcan Energy team up to scale Europe’s sustainable lithium supply

  Framework deal names a preferred automation/digitalization supplier for Lionheart, Europe's first integrated lithium+renewables project: 24,000 t LHM/yr; 275 GWh power; 560 GWh heat; 30-yr life
• 

  14 April 2026

  Novo Nordisk partners with OpenAI to speed drug discovery and delivery

  Integrate advanced AI across drug discovery, manufacturing, supply chain and commercial ops to speed development, upskill staff; pilots now, full integration by end-2026; strict governance.
• 

  10 April 2026

  WPU (Vitol) to build 80,000 t/yr chemical plastics recycling plant in Rotterdam

  Uses batch pyrolysis to turn end-of-life plastics into pyrolysis oil as naphtha substitute; tech proven at a 20k t/yr Denmark plant; ties into VPR and Vopak storage.
• 

  9 April 2026

  Worley Rosenberg awarded FEED for RjukanLH2, Nordic’s first liquid hydrogen plant

  FEED (with EPC option) for 25 MW liquid hydrogen plant (10 t/day); modular design with pressurized alkaline electrolyzers and liquefaction; PPA-secured renewable power; production from 2028.

• 

  6 April 2026

  Trinseo: The Node That Ran Out of Time

  Lender waivers expiring; missed interest; market cap far below debt. Costly M&A and validated PC/ABS dissolution recycling tech, but cash‑strapped amid energy shocks and no sovereign backer—sale likely.
• 

  23 March 2026

  Equinor adds 230 MW Esquina do Vento wind complex in Brazil

  Acquired ready-to-build 51-turbine onshore wind complex; expands onshore renewables and storage platform, supports integrated wind/solar/trading strategy, targets ~1 TWh/year and double-digit returns.
• 

  19 March 2026

  bp to sell Gelsenkirchen refinery to Klesch Group

  Sale of Gelsenkirchen refinery raises structural cost-cut target by ~$1bn to $6.5-7.5bn by 2027, strengthens balance sheet, is free-cash-flow accretive; 12Mtpa, ~1,800 staff; close H2 2026.
• 

  17 March 2026

  Ørsted Employees Elected to Board

  Three employees were elected to Ørsted's Board of Directors, joining after the annual meeting on April 9, 2026.
• 

  17 March 2026

  Thor Offshore Wind Farm Begins Power Generation, Reports RWE

  Thor offshore wind farm starts feeding electricity into Denmark's grid, aiming to power over one million homes by 2027 with sustainable features and local job creation.
• 

  10 March 2026

  RWE Sells Polish Offshore Wind Project to PGE

  PGE acquires 350 MW F.E.W. Baltic II project and Environmental Decision for site 44.E.1. RWE continues to support Poland's energy transition with onshore wind and solar projects.
• 

  10 March 2026

  ORLEN Confirms Gas Discovery in North Sea's Sleipner Area

  Gas and condensate found in Frida Kahlo prospect, estimated at 7.2 million barrels. Production to start by 2026 using existing infrastructure, reducing costs and time.
• 

  9 March 2026

  Novo Nordisk Partners with Hims & Hers to Expand Access to Semaglutide in the US

  Hims & Hers will offer FDA-approved semaglutide medicines at self-pay prices, shifting focus from compounded GLP-1 offerings to increase patient access.
• 

  4 March 2026

  Topsoe Appoints Elena Scaltritti as CEO

  Roeland Baan steps down early as CEO, with Elena Scaltritti taking over on March 5, 2026, following a smooth transition and strong strategic alignment.
• 

  4 March 2026

  Topsoe's 2025 Financial Results Meet Expectations in Tough Market

  Revenue reached DKK 8,197 million. EBIT margin at 8.9%. SAF projects in China. New CEO from March 2026. 2026 outlook: revenue DKK 7,600-8,400 million, EBIT margin 0.0-5.0%.
• 

  2 March 2026

  Novo Nordisk Employee Board Elections Completed

  Four employee representatives and four substitutes were elected to Novo Nordisk's Board. New members join post-AGM on 26 March 2026. Two current members will resign.
• 

  25 February 2026

  Novo Nordisk and Vivtex Collaborate on Oral Medicines for Obesity and Diabetes

  The partnership aims to develop oral biologics for obesity and diabetes, leveraging Vivtex's technology for better bioavailability and Novo Nordisk's expertise in global development and commercialization.
• 

  25 February 2026

  Worley Wins EPCM Contract for Danish Hydrogen Pipeline

  Worley to provide EPCM services for Denmark's hydrogen pipeline, linking green hydrogen production with Germany, enhancing energy security and supporting the green transition.
• 

  24 February 2026

  Genmab Share Capital Increase from Employee Warrant Exercise

  12,313 new shares issued, raising DKK 17.1 million. New shares have no special rights and will be listed on Nasdaq Copenhagen. Total share capital now 64,250,721 shares.
• 

  24 February 2026

  Novo Nordisk's UBT251 Achieves 19.7% Weight Loss in Phase 2 China Trial

  UBT251, a triple agonist, showed significant weight loss and improved health markers in a Chinese phase 2 trial, with a safe and well-tolerated profile.
• 

  23 February 2026

  Novo Nordisk: CagriSema Shows 23% Weight Loss in Trial, Misses Primary Endpoint

  CagriSema achieved 23% weight loss in 84 weeks but didn't match tirzepatide. Further trials will explore higher doses. Safe profile with mild gastrointestinal effects.
• 

  12 February 2026

  thyssenkrupp Q1 2025/2026: Sales Down, EBIT Up, Forecast Confirmed

  Order intake fell due to prior major contracts. Sales dropped 8%, but EBIT rose 10% via APEX program. Transformation progresses with strategic moves in various segments.
• 

  9 February 2026

  Novo Nordisk Sues Hims & Hers Over Unapproved Semaglutide Products

  Novo Nordisk seeks to stop Hims from selling unapproved semaglutide, citing patient safety risks and patent infringement.
• 

  6 February 2026

  Neste Names Jukka Siukosaari as SVP of Public Affairs and Geopolitics

  Jukka Siukosaari, former Finnish ambassador, joins Neste's leadership team to focus on public affairs and geopolitics, leveraging his diplomatic experience for the energy transition.
• 

  5 February 2026

  SPIE Advances ALK's Low-Carbon Transition at Vandeuil Plant

  SPIE replaced gas boilers with heat pumps at ALK's Vandeuil site, cutting CO2 emissions by 305 tons annually and enhancing energy efficiency.
• 

  4 February 2026

  Kemira Enters Finland's Top 5 in Nordic Diversity Index

  Kemira improved its diversity ranking, focusing on gender, age, nationality, and education. The 2026 report highlights AI's role in digital leadership.
• 

  4 February 2026

  Worley Backs AquaDuctus Hydrogen Pipeline in North Sea

  AquaDuctus, a key project in Europe's hydrogen infrastructure, will connect offshore production to the mainland, supporting cross-border collaboration and green hydrogen deployment.
• 

  2 February 2026

  Court Allows Ørsted's Sunrise Wind Project to Resume Construction

  A U.S. court lifted a suspension, allowing the Sunrise Wind Project to restart construction, prioritizing safety and aiming to provide reliable power to New York.
• 

  2 February 2026

  Ørsted Announces New Employee-Elected Board Member

  Leticia Mandiola steps down from Ørsted's board. Arul Gynasegaran, Senior Project Lead, replaces her as the new employee-elected board member.